For research use only. Not for therapeutic Use.
Talquetamab（Cat No.:I042202）is a bispecific monoclonal antibody designed to target two distinct proteins: CD3, a receptor on T-cells, and GPRC5D, a tumor-associated antigen expressed on multiple myeloma cells. By engaging T-cells through CD3 and directing them to GPRC5D-expressing cancer cells, talquetamab aims to activate the immune system to specifically target and kill myeloma cells. It is being studied in clinical trials for its potential in treating relapsed or refractory multiple myeloma, with a focus on its safety, efficacy, and ability to improve patient outcomes in this challenging cancer.
| Catalog Number | I042202 |
| CAS Number | 2226212-40-2 |
| Purity | ≥95% |
